Heron Cash Flow Coverage Ratios from 2010 to 2024

HRTX Stock  USD 1.14  0.07  6.54%   
Heron Therapeuti Cash Flow Coverage Ratios yearly trend continues to be fairly stable with very little volatility. Cash Flow Coverage Ratios will likely drop to -0.35 in 2024. During the period from 2010 to 2024, Heron Therapeuti Cash Flow Coverage Ratios regression line of annual values had significance of  0.02 and arithmetic mean of (20.79). View All Fundamentals
 
Cash Flow Coverage Ratios  
First Reported
2010-12-31
Previous Quarter
(0.33)
Current Value
(0.35)
Quarterly Volatility
22.35559032
 
Credit Downgrade
 
Yuan Drop
 
Covid
Check Heron Therapeuti financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Heron Therapeuti's main balance sheet or income statement drivers, such as Depreciation And Amortization of 3 M, Interest Expense of 4.1 M or Total Revenue of 133.4 M, as well as many indicators such as Price To Sales Ratio of 1.76, Dividend Yield of 0.0 or Days Sales Outstanding of 110. Heron financial statements analysis is a perfect complement when working with Heron Therapeuti Valuation or Volatility modules.
  
Check out the analysis of Heron Therapeuti Correlation against competitors.
For more information on how to buy Heron Stock please use our How to Invest in Heron Therapeuti guide.

Latest Heron Therapeuti's Cash Flow Coverage Ratios Growth Pattern

Below is the plot of the Cash Flow Coverage Ratios of Heron Therapeuti over the last few years. It is Heron Therapeuti's Cash Flow Coverage Ratios historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Heron Therapeuti's overall financial position and show how it may be relating to other accounts over time.
Cash Flow Coverage Ratios10 Years Trend
Slightly volatile
   Cash Flow Coverage Ratios   
       Timeline  

Heron Cash Flow Coverage Ratios Regression Statistics

Arithmetic Mean(20.79)
Coefficient Of Variation(107.51)
Mean Deviation18.60
Median(16.50)
Standard Deviation22.36
Sample Variance499.77
Range74.6287
R-Value0.59
Mean Square Error347.95
R-Squared0.35
Significance0.02
Slope2.97
Total Sum of Squares6,997

Heron Cash Flow Coverage Ratios History

2024 -0.35
2023 -0.33
2022 -0.97
2021 -1.34
2020 -18.39
2019 -16.5
2018 -41.93

About Heron Therapeuti Financial Statements

Heron Therapeuti investors use historical fundamental indicators, such as Heron Therapeuti's Cash Flow Coverage Ratios, to determine how well the company is positioned to perform in the future. Understanding over-time patterns can help investors decide on long-term investments in Heron Therapeuti. Please read more on our technical analysis and fundamental analysis pages.
Last ReportedProjected for Next Year
Cash Flow Coverage Ratios(0.33)(0.35)

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Additional Tools for Heron Stock Analysis

When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.